Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care

Manuscript Number:

21-0335R1

Author(s):

Francesco Di Lorenzo, Kristian Steen Frederiksen, Jean Georges, Jakub Hort, Flavio Nobili, Marta Scarioni, Svetlana Tomic, Sofia Toniolo

Disclosures

Equity:
Agora pharmaceuticals - shares, Alzheon - stock options

Lecture Fees:
Lundbeck - less than 1000 E

Consulting Fees:
fees for board participation from Roche and Bial

Lecture Fees:
fees for teaching course from G.E. Healthcare and Biogen

Consulting Fees:
Advisory board on treatment of advanced Parkinson`s disease stage payed from Pheonix Pharmacia d.o.o. Fee around 1000 euros.

Lecture Fees:
Speaking fee from AbbVie d.o.o. for reports on PD patients treatment during the pandemia and participation on few round table meeting on PD patients treatment. Fees around 500 euros for each participation. Speaking fee from Pliva Hrvatska d.o.o. for lectures on Non motor symptoms in Parkinson disease; Azilect in PD treatment and Pregabalin. Fees around 400 euros. Speaking fee from Sanofi-Aventis Croatia d.o.o. for lectures on sleep disturbances in neuromuscular disorders. Fee around 600 euros. Speaking fee from Phoenix Pharmacia d.o.o. for lectures on Stalevo in treatment for Parkinson`s disease. Fee around 550 euros. Speaking fee from Novartis Hrvatska d.o.o. for few lectures in migreana treatment. Each fee around 800 euros. Speaking fee from Fresenius Kabi d.o.o. for lectures on malnutrition and vitamine D3 supplement in neurodegenerative diseases. Fee around 400 euros. Speaking fee from Makpharm d.o.o. for lectures on Motor neuron disease. Fee around 500 euros. Speaking fee from Medis Adria d.o.o. for lectures on Xeomin in treatment of cervical dystonia. Fee around 500 euros. Speaking fee from Merz Pharmaceuticals GmbH for lectures on Xeomin treatment in cervical dystonia patients during the pandemia. Fee around 150 euros.